Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis

Ann Rheum Dis. 2019 Feb;78(2):282-284. doi: 10.1136/annrheumdis-2018-214025. Epub 2018 Oct 8.

¹ Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, Korea.
² Rheumatology Department, Université Paris-Sud, INSERM UMR1184, Immunology of Viral Infections and Autoimmune Diseases, Hôpitaux Universitaires Paris-Sud-Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France.
³ Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA.
⁴ Division of Medical Statistics, Medical Research Collaborating Center, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
⁵ Rheumatology Department, Université Paris-Sud, INSERM UMR1184, Immunology of Viral Infections and Autoimmune Diseases, Hôpitaux Universitaires Paris-Sud-Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin Bicêtre, France xavier.mariette@aphp.fr.

^# Contributed equally.

No abstract available

Keywords: BAFF; methotrexate; rheumatoid arthritis; vaccination.

Publication types